HSBC Call 350 AMGN 17.01.2025/ DE000HS3XAN9 /
10/01/2025 08:18:16 | Chg.0.000 | Bid10/01/2025 | Ask10/01/2025 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.001EUR | 0.00% | 0.001 Bid Size: 50,000 |
0.065 Ask Size: 50,000 |
Amgen Inc | 350.00 USD | 17/01/2025 | Call |
GlobeNewswire
29/08/2024
Great Place To Work Announces the 2024 Best Workplaces in Asia Representing 6.9 Million Employee Exp...
GlobeNewswire
28/08/2024
Prevent Cancer Annual Gala to celebrate three decades of commitment to cancer prevention and early d...
GlobeNewswire
15/08/2024
Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of ...
GlobeNewswire
12/08/2024
TScan Therapeutics Reports Second Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire
08/08/2024
CytomX Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
08/08/2024
Ardelyx Appoints Experienced Biopharma Executive, Eric Foster, as Chief Commercial Officer
GlobeNewswire
05/08/2024
Avalyn Appoints Erin Lavelle, Seasoned Biopharma Finance Executive, to its Board of Directors
GlobeNewswire
01/08/2024
CytomX Therapeutics to Report Second Quarter 2024 Financial Results on August 8, 2024